Creatine Kinase MB Isoenzyme Is a Complementary Biomarker in Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is an invariably fatal neurodegenerative disease with limited therapeutic options. There is an urgent need for novel biomarkers to be used as surrogates for new therapeutic trials and disease monitoring. In this study, we sought to systematically study creatine ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Kittipeerapat, Natsinee, Fabian, Rachel, Bernsen, Sarah, Weydt, Patrick, Castro-Gomez, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380590/
https://www.ncbi.nlm.nih.gov/pubmed/37511443
http://dx.doi.org/10.3390/ijms241411682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380590/
https://www.ncbi.nlm.nih.gov/pubmed/37511443
http://dx.doi.org/10.3390/ijms241411682

Ejemplares similares